Abstract
The original version of this article unfortunately contains a confused expression. The demonstration of the treatment dose has missed some detailed information in the second and third paragraph of the Study design and treatment column on the third page. The sentences replacement and the supplementary table are as follow: “Subjects in the AESB and placebo groups received bags of 4.5 g AESB, with 200 mg extract plus other added excipients (Table S9 in the Supplements, the added components have used to maintain the feature and flavor to be acceptable for a long-term consumption) or 4.5 g placebo (Table S9 in the supplements), respectively, which were taken daily with warm water before bedtime for 2 months. The extract in AESB samples contained a total of 16.31% glucosinolates as assessed by HPLC–MS (QTOF and UV), 14.10% of which was glucoraphanin (Table S8 in the Supplements).”
Original language | English |
---|---|
Pages (from-to) | 2549 |
Number of pages | 1 |
Journal | Inflammopharmacology |
Volume | 30 |
Issue number | 6 |
DOIs |
|
Publication status | Published - Dec 2022 |
Externally published | Yes |